J&J pulls COVID vaccine sales forecast due to low demand, supply glut
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/14/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Johnson & Johnson (JNJ) PT Raised to $205 at Credit Suisse
April 20, 2022 6:51 AM EDTCredit Suisse analyst Matt Miksic raised the price target on Johnson & Johnson (NYSE: JNJ) to $205.00 (from $200.00) while maintaining a Outperform rating.
... MoreJohnson & Johnson (JNJ) PT Raised to $196 at Raymond James
April 20, 2022 5:56 AM EDTRaymond James analyst Jayson Bedford raised the price target on Johnson & Johnson (NYSE: JNJ) to $196.00 (from $195.00) while maintaining a Outperform rating following results.
The analyst commented, "1Q results were mixed and the downward guidance revision, although not operational, still causes us to... More
Johnson & Johnson (JNJ) PT Raised to $210 at Citi
April 19, 2022 3:11 PM EDTCiti analyst Joanna Wuensch raised the price target on Johnson & Johnson (NYSE: JNJ) to $210.00 (from $203.00) while maintaining a Buy rating following earnings.
... More